Volver a Agenda
Panel Discussion
Session Chair(s)
Kazuhiko Ishida, MSC, RPH
Director, Pharmacovigilance
Astellas Pharma Inc., Japan
Hiroki Nagahama, MS
Director, Japan Safety Risk Management Lead, Clinical Safety & Pharmacovigilance
GlaxoSmithKline K.K., Japan
Speaker(s)
Toyotaka Iguchi, MD, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of Safety II
Masahiro Ohba
Isehara Kyodo Hospotal, Japan
Hideo Nakada, RPH
Keio University, Japan
Deputy Associate Manager, Department of Hospital Pharmacy
Kazuhiro Keitoku
Beone Medicines Japan, Japan
Director, Head of Global Patient Safety, Japan
Naoto Oiri
Chugai Pharmaceutical Co., Ltd., Japan
Emiko Iida, MPHARM
Daiichi Sankyo Co Ltd, Japan
¿Tiene una cuenta?